Search
NovaBay Pharmaceuticals Inc
NBYAdd to Watchlist
1.950USD
0.0000.00%
Close 06/17, 16:00（ET）Quotes delayed by 15 min
32.27MMarket Cap
LossP/E TTM
Financial Health
Currency: USD Updated: 2026-04-02 The current financial score of NovaBay Pharmaceuticals Inc is 7.00, ranking 125 out of 157 in the Pharmaceuticals industry. Its financial status is robust, and its operating efficiency is low.
Financials
8.75
Cash and cash equivalents
Total assets
Total liabilities
Free cash flow
Relevant data have not been disclosed by the company yet.
Quality of Earnings
8.04
Total revenue
Operating profit
Total assets
SG&A
Relevant data have not been disclosed by the company yet.
Operational Efficiency
5.73
Cash flow from operating activities
Income after tax
Relevant data have not been disclosed by the company yet.
Growth Potential
5.58
Cash flow from operating activities
Total revenue
Relevant data have not been disclosed by the company yet.
Shareholder Returns
6.88
Free cash flow
Relevant data have not been disclosed by the company yet.
